Overview

Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)

Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This study was designed to determine efficacy of TREXIMET (sumatriptan/naproxen sodium), formerly known as TREXIMA compared to placebo for the treatment of a menstrual migraine.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Naproxen
Sumatriptan